Overview Financials News + Filings Key Docs Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Jun-30-22 | Mar-31-22 | Jun-30-21 |
| | 8-K | 8-K | 10-Q | 8-K | 10-Q |
| Revenues: |
| Home Health | | | 2.7 | | 3.8 |
| Hospice | | | 47.8 | | 53.8 |
| Other | | | 217.5 | | 228.5 |
| Total revenues | 262.3 | 265.1 | 268.0 | 274.3 | 286.1 |
| Revenue growth [+] | -2.1% | -3.4% | -6.3% | | |
| Home Health | | | -28.9% | | |
| Hospice | | | -11.2% | | |
| Cost of goods sold | 135.5 | 132.6 | 130.3 | 129.7 | 129.6 |
| Gross profit | 126.8 | 132.5 | 137.7 | 144.6 | 156.5 |
| Gross margin | 48.3% | 50.0% | 51.4% | 52.7% | 54.7% |
| Selling, general and administrative [+] | 107.8 | 110.5 | 102.2 | 100.7 | 105.7 |
| General and administrative | 107.8 | 110.5 | 102.2 | 100.7 | 105.7 |
| Equity in earnings | | | | | -0.2 |
| Other operating expenses | | 7.8 | | 8.5 | |
| EBITDA [+] | 19.0 | 22.0 | 35.5 | 43.9 | 50.6 |
| EBITDA growth | -46.5% | -49.9% | -29.8% | | |
| EBITDA margin | 7.2% | 8.3% | 13.2% | 16.0% | 17.7% |
| Depreciation and amortization | 7.7 | 7.8 | 8.2 | 8.5 | 9.4 |
| EBIT [+] | 11.3 | 14.2 | 27.3 | 35.4 | 41.2 |
| EBIT growth | -58.6% | -59.9% | -33.7% | | |
| EBIT margin | 4.3% | 5.4% | 10.2% | 12.9% | 14.4% |
| Non-recurring items [+] | 85.8 | | | | |
| Asset impairment | 85.8 | | | | |
| Interest expense | | | 0.1 | | |
| Interest expense | | | 0.1 | | |
| Other income (expense), net [+] | -10.2 | -9.5 | | | 2.0 |
| Other non-operating income | | | | | -1.6 |
| Other | -0.1 | | | | |
| Pre-tax income | -84.7 | 4.7 | 27.2 | 35.4 | 43.2 |
| Income taxes | -10.6 | 1.5 | 6.4 | 8.7 | 10.4 |
| Tax rate | 12.5% | 31.9% | 23.5% | 24.6% | 24.1% |
| Minority interest | | | 0.7 | | 0.5 |
| Net income | -74.4 | 2.7 | 20.1 | 26.1 | 32.3 |
| Net margin | -28.4% | 1.0% | 7.5% | 9.5% | 11.3% |
| |
| Basic EPS [+] | ($1.49) | $0.05 | $0.41 | $0.53 | $0.65 |
| Growth | -467.7% | -90.6% | -37.8% | | |
| Diluted EPS [+] | ($1.49) | $0.05 | $0.41 | $0.53 | $0.65 |
| Growth | -467.7% | -90.6% | -37.8% | | |
| |
| |
| Shares outstanding (basic) [+] | 49.9 | 54.0 | 49.6 | 49.2 | 49.6 |
| Growth | 0.7% | 9.7% | 0.0% | | |
| Shares outstanding (diluted) [+] | 49.9 | 54.0 | 49.6 | 49.2 | 49.6 |
| Growth | 0.7% | 9.7% | 0.0% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|